TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29580871

Group type: EXPERIMENTAL
Intervention: Oral Vitamin D supplementation
Number of subjects: 60
Study: 27916475

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) at breakfast
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) at midmorning
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 26537945

Group type: EXPERIMENTAL
Intervention: Fructose-sweetened beverage
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Glucose-sweetened beverage
Number of subjects: 33

Group type: COMPARATOR
Intervention: Aspartame-sweetened beverage
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-fructose corn syrup (HFCS)-sweetened beverage
Number of subjects: 33
Study: 23153410

Group type: EXPERIMENTAL
Intervention: Post-prescription review by the infectious disease physician (IDP)
Number of subjects: 753

Group type: COMPARATOR
Intervention: No systematic review of the prescription
Number of subjects: 753
Study: 21703596

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study: 19048842

Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combined therapy with melatonin
Number of subjects: 43
Study: 16780597

Group type: EXPERIMENTAL
Intervention: Remifentanil/Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Midazolam/Fentanyl
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 15516601

Group type: EXPERIMENTAL
Intervention: 20-mL test bolus with 100-mL main bolus (group 1)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Bolus tracking with 100-mL main bolus (group 2)
Number of subjects: 38
Study: 11775301

Group type: EXPERIMENTAL
Intervention: Coached behavioral intervention to promote maternal-infant responsiveness
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no coached intervention)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both groups (treatment and control)
Number of subjects: 117
Study: 9433609

Group type: EXPERIMENTAL
Intervention: WPC approach for genetic linkage tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization of alleles following Mendelian laws
Number of subjects: 0
Study: 8498949

Group type: EXPERIMENTAL
Intervention: Norethisterone-containing pill
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levonorgestrel-containing pill
Number of subjects: 0
Study: 3113475

Group type: EXPERIMENTAL
Intervention: Piperazine oestrone sulphate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 30843767

Group type: EXPERIMENTAL
Intervention: 30 g/day milled flaxseed for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lifestyle advice
Number of subjects: 50
Study: 31689127

Group type: EXPERIMENTAL
Intervention: Dermalax injection
Number of subjects: 324

Group type: COMPARATOR
Intervention: Restylane injection
Number of subjects: 324
Study: 31746480

Group type: EXPERIMENTAL
Intervention: Late implant placement following alveolar ridge preservation (LP/ARP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Early implant placement (EP)
Number of subjects: 16
Study: 30573057

Group type: EXPERIMENTAL
Intervention: Ridaforolimus-eluting stents
Number of subjects: 1919

Group type: COMPARATOR
Intervention: Zotarolimus-eluting stents
Number of subjects: 1919

Group type: EXPERIMENTAL
Intervention: Angiographic follow-up
Number of subjects: 1919
Study: 28701670

Group type: EXPERIMENTAL
Intervention: Compound Hypertonic Saline Solution (C‐HSS) with high dose furosemide (100 mg) plus C‐HSS (100 mL) twice daily
Number of subjects: 264

Group type: COMPARATOR
Intervention: Furosemide intravenous bolus (100 mg) twice a day without C‐HSS
Number of subjects: 264
Study: 25515657

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 2230

Group type: EXPERIMENTAL
Intervention: dNLR ≥ median (2)
Number of subjects: 2230

Group type: EXPERIMENTAL
Intervention: Duration of initial ADT < median (15 months)
Number of subjects: 2230

Group type: EXPERIMENTAL
Intervention: dNLR
Number of subjects: 2230

Group type: EXPERIMENTAL
Intervention: Duration of initial ADT
Number of subjects: 2230
Study: 24040849

Group type: EXPERIMENTAL
Intervention: Ticagrelor 900 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ticagrelor 1,260 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20640381

Group type: EXPERIMENTAL
Intervention: High-intensity physical training (n=29) at 85% maximum heart rate for 12 weeks
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Moderate-intensity training (n=29) at 75% maximum heart rate for 12 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (n=29)
Number of subjects: 87
Study: 18187401

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 177
Study: 16368841

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (7.5 cm H2O)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (spontaneous breathing at ambient pressure)
Number of subjects: 20
Study: 15463871

Group type: EXPERIMENTAL
Intervention: Nebulised rhDNase (2.5 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: NaCl 0.9% (10 ml)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Overnight pulse oximetry
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Daily symptom scores
Number of subjects: 9
Study: 11297000

Group type: EXPERIMENTAL
Intervention: Water exercise (WA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Land exercise (LN)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Arms and legs exercise
Number of subjects: 12
Study: 8873932

Group type: EXPERIMENTAL
Intervention: 500 IU/day of vitamin E
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1000 IU/day of vitamin E
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1500 IU/day of vitamin E
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 1889071

Group type: EXPERIMENTAL
Intervention: Migraine patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 18
Study: 6388713

Group type: EXPERIMENTAL
Intervention: Motival (0.5 mg fluphenazine with 10 mg nortriptyline) 3 times daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31676515

Group type: EXPERIMENTAL
Intervention: Silicone foam dressing changed every 3 days
Number of subjects: 127

Group type: COMPARATOR
Intervention: Gauze and tape dressing changed once daily
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Gauze and tape dressing changed every 3 days
Number of subjects: 127

Group type: COMPARATOR
Intervention: Gauze and tape dressing (general)
Number of subjects: 127
Study: 30059701

Group type: EXPERIMENTAL
Intervention: Music (MU)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No-music (CO)
Number of subjects: 19
Study: 27561194

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2331
Study: 24963568

Group type: EXPERIMENTAL
Intervention: Earlier ART initiation (1 to 2 weeks after diagnosis)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Deferred ART initiation (5 weeks after diagnosis)
Number of subjects: 177
Study: 23085712

Group type: EXPERIMENTAL
Intervention: Mouth rinse with 26.9% alcohol (Listerine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mouth rinse with no alcohol
Number of subjects: 60
Study: 19940514

Group type: EXPERIMENTAL
Intervention: Presence of ischemic lesions in brain regions
Number of subjects: 1403

Group type: EXPERIMENTAL
Intervention: Age, hypertension, cognitive impairment
Number of subjects: 1403

Group type: EXPERIMENTAL
Intervention: History of smoking
Number of subjects: 1403

Group type: EXPERIMENTAL
Intervention: Cognitive function tests
Number of subjects: 1403
Study: 17995861

Group type: EXPERIMENTAL
Intervention: Product B (7.5% emulsifier)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Product C (15% emulsifier)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Product A (0% emulsifier)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Commercial wheat-based butter cake
Number of subjects: 400
Study: 15749623

Group type: EXPERIMENTAL
Intervention: Soy protein diet (25 g soy/4.2 MJ)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Isoflavone diet (50 mg isoflavones/4.2 MJ)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Animal protein diet
Number of subjects: 42
Study: 11927473

Group type: COMPARATOR
Intervention: Propofol anesthesia with rocuronium (0.5 mg/kg at induction, followed by 0.3 mg/kg one hour later)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia with rocuronium (0.5 mg/kg at induction, followed by 0.3 mg/kg one hour later)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 10
Study: 11372092

Group type: EXPERIMENTAL
Intervention: Education group; received education materials about sealants.
Number of subjects: 312

Group type: COMPARATOR
Intervention: No Education group; received no education materials until after the education phase.
Number of subjects: 312
Study: 7552316

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the right index finger (task somatosensory evoked fields, task SEF's)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Voluntary movement of the right index finger (movement-related fields, MRFs)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control SEF's recorded at the beginning of the experiment
Number of subjects: 5
Study: 2355105

Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 369395

Group type: EXPERIMENTAL
Intervention: Injectable haloperidol (initial doses ranging from 1 to 30 mg, maximum total daily dosage of 100 mg)
Number of subjects: 650
Study: 31419583

Group type: EXPERIMENTAL
Intervention: 36 amino acid peptide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized peptide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 28972191

Group type: EXPERIMENTAL
Intervention: Daily acute intermittent hypoxia (AIH) + hand opening practice
Number of subjects: 6
Study: 26513698

Group type: EXPERIMENTAL
Intervention: Slow breathing training (SBT) using the RESPeRATE device, 10-12 weeks duration, 2 sessions of 15 minutes daily at 6 breaths/min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SBT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care followed by SBT
Number of subjects: 40
Study: 24410903

Group type: EXPERIMENTAL
Intervention: Walnut meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: Refined control meal
Number of subjects: 16
Study: 22930087

Group type: EXPERIMENTAL
Intervention: Mitomycin C application to the tympanic membrane before myringotomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline application to the tympanic membrane before myringotomy (Control)
Number of subjects: 40
Study: 19672601

Group type: EXPERIMENTAL
Intervention: Balneotherapy/Hydrotherapy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mild Infrared Hyperthermia
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mesendieck System
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Connective Tissue Massage
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Osteopathy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Magnet Therapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Qi Gong
Number of subjects: 25

Group type: COMPARATOR
Intervention: Biofeedback
Number of subjects: 25

Group type: COMPARATOR
Intervention: Body Awareness Therapy
Number of subjects: 25
Study: 18055949

Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 0
Study: 16876249

Group type: EXPERIMENTAL
Intervention: VEGF Trap 0.3 mg/kg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: VEGF Trap 1.0 mg/kg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: VEGF Trap 3.0 mg/kg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 12152639

Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal preperitoneal patch technique (TAPP)
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Shouldice technique
Number of subjects: 1042
Study: 10200011

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aerosol 88 microg twice daily
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aerosol 220 microg twice daily
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aerosol 200 microg 4 times daily
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aerosol 400 microg twice daily
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Prednisone 10 mg once daily
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 7598932

Group type: EXPERIMENTAL
Intervention: 100% oxygen (O2) for 1 minute
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 100% oxygen (O2) for 2 minutes
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 100% oxygen (O2) for 3 minutes
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Succinylcholine 1.5 mg/kg (Group 4)
Number of subjects: 40
Study: 1977869

Group type: EXPERIMENTAL
Intervention: High protein (2.5‐3.0 g/kg), high calorie (BEE x 1.2 x 1.6) diet
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderately high protein (2.0‐2.5 g/kg), high calorie diet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal protein (1‐1.5 g/kg), normal calorie (30‐35 Kcal/kg) diet
Number of subjects: 60
Study: 874673

Group type: EXPERIMENTAL
Intervention: Phototherapy (Group I)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Phototherapy (Group II)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (Group I)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (Group II)
Number of subjects: 2
Study: 30844992

Group type: EXPERIMENTAL
Intervention: Hang cleans at 90% of 1 repetition maximum (1RM)
Number of subjects: 12
Study: 30465635

Group type: EXPERIMENTAL
Intervention: Aerobic training in mineral geothermal water (2 days/week, 30-40 minutes, 60%-75% of HRmax)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 20
Study: 31083056

Group type: EXPERIMENTAL
Intervention: Blended collaborative care for depression and HFrEF
Number of subjects: 750

Group type: COMPARATOR
Intervention: Enhanced usual care for HFrEF
Number of subjects: 750

Group type: COMPARATOR
Intervention: Usual care (UC) for HFrEF
Number of subjects: 750
Study: 27861238

Group type: COMPARATOR
Intervention: Low ICFI score (compared to high ICFI score)
Number of subjects: 2092

Group type: COMPARATOR
Intervention: Low dietary diversity score (compared to high dietary diversity score)
Number of subjects: 2092

Group type: COMPARATOR
Intervention: Low food consistency score
Number of subjects: 2092
Study: 26074027

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: VIABAHN stent graft placement
Number of subjects: 14
Study: 23523291

Group type: EXPERIMENTAL
Intervention: Best Clinical Judgment (BCJ) with PCA3
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Best Clinical Judgment (BCJ) alone
Number of subjects: 1024

Group type: COMPARATOR
Intervention: PCA3 alone (cutoff score 20)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: BCJ with PCA3
Number of subjects: 1024
Study: 21762871

Group type: EXPERIMENTAL
Intervention: Fish oil (4.6 g/day of long-chain ω-3 fatty acids)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control oil
Number of subjects: 200
Study: 19415308

Group type: EXPERIMENTAL
Intervention: Fast-track (FT) protocols
Number of subjects: 1021

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1021
Study: 16264050

Group type: EXPERIMENTAL
Intervention: Cotton dust exposure
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Cotton dust exposure cessation
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Persistent byssinotic symptoms
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Endotoxin exposure
Number of subjects: 447

Group type: COMPARATOR
Intervention: Silk textile control
Number of subjects: 447
Study: 10494875

Group type: EXPERIMENTAL
Intervention: Postmenarcheal girls
Number of subjects: 300

Group type: COMPARATOR
Intervention: Pre- and postmenarcheal girls
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Postmenarcheal adolescents
Number of subjects: 300

Group type: COMPARATOR
Intervention: Healthy girls and young women
Number of subjects: 300
Study: 7500246

Group type: EXPERIMENTAL
Intervention: Titanium reinforced membranes positioned just apical to the cemento-enamel junction and the modified papilla preservation technique
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional expanded polytetrafluoroethylene (ePTFE) barrier membranes applied at the alveolar crest
Number of subjects: 45

Group type: COMPARATOR
Intervention: Access flap procedure
Number of subjects: 45
Study: 1773454

Group type: EXPERIMENTAL
Intervention: Ke Chuan Ping decoction (KCP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Traditional prescription Qing Jin Hua Tan decoction (QJHT)
Number of subjects: 62
Study: 6813483

Group type: EXPERIMENTAL
Intervention: Auranofin (AF)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Sodium aurothiomalate (GSTM)
Number of subjects: 103
Study: 31846375

Group type: EXPERIMENTAL
Intervention: PACS-integrated peer review tool
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nonadopters group (control)
Number of subjects: 38
Study: 30860197

Group type: EXPERIMENTAL
Intervention: Short-stay protocol (ambulated and graded oral intake initiated from 6 h post-operation, urethral catheters discontinued at 12 h, discharged on the 3rd day post-op)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional protocol (ambulated from 12 h, graded oral intake initiated at 24 h, urethral catheters removed at 24 h, discharged on the 5th day post-op)
Number of subjects: 0
Study: 30498520

Group type: EXPERIMENTAL
Intervention: 30 seconds of weight-bearing heel raises
Number of subjects: 48
Study: 26908726

Group type: EXPERIMENTAL
Intervention: 2D (M0,6)
Number of subjects: 1447

Group type: EXPERIMENTAL
Intervention: 2D (M0,12)
Number of subjects: 1447
Study: 24248149

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation programme (adapted physical activity within a cognitive behavioural framework)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 60
Study: 21781012

Group type: EXPERIMENTAL
Intervention: Fluconazole 1% and urea 40%
Number of subjects: 70

Group type: COMPARATOR
Intervention: Fluconazole 1% alone
Number of subjects: 70
Study: 19463080

Group type: EXPERIMENTAL
Intervention: Exercise program (eight classes of 40-45 minutes duration over eight weeks conducted by a physiotherapist)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 17565288

Group type: EXPERIMENTAL
Intervention: Care for Development (CFD) counseling materials provided to 50 families
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (50 families without CFD counseling)
Number of subjects: 100
Study: 15031565

Group type: COMPARATOR
Intervention: Moderate asthma patients
Number of subjects: 133

Group type: COMPARATOR
Intervention: Asthma patients (both mild and moderate)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Subjects with slightly elevated CRP levels (> or =1.8 mg/l)
Number of subjects: 133
Study: 12083284

Group type: EXPERIMENTAL
Intervention: Structured Play (SP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Facilitated Play (FP)
Number of subjects: 8
Study: 9690059

Group type: EXPERIMENTAL
Intervention: Outpatient structured diabetes treatment and teaching programme (DTTP)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Inpatient structured diabetes treatment and teaching programme (DTTP)
Number of subjects: 72
Study: 7654895

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 286

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 286
Study: 29091516

Group type: EXPERIMENTAL
Intervention: Bosutinib 400 mg once daily (n = 268)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Imatinib (n = 268)
Number of subjects: 536
Study: 28865495

Group type: EXPERIMENTAL
Intervention: left prefrontal rTMS treatment
Number of subjects: 360

Group type: COMPARATOR
Intervention: sham (control) rTMS treatment
Number of subjects: 360
Study: 26634593

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) at dosage of 2000 UI
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) at dosage of 4000 UI
Number of subjects: 61
Study: 22998461

Group type: EXPERIMENTAL
Intervention: PRGF
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study: 21150855

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol and remifentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inhalational anesthesia (INHAL) with sevoflurane and fentanyl
Number of subjects: 50
Study: 19563193

Group type: EXPERIMENTAL
Intervention: Acupuncture plus Chinese medicine (group ACUP+CM)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (group CONT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Chinese medicine group (group CM)
Number of subjects: 90
Study: 18705976

Group type: EXPERIMENTAL
Intervention: B vitamins (folic acid 2 mg, B(6) 25 mg, B(12) 500 microg)
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: B vitamins
Number of subjects: 8000
Study: 15526253

Group type: EXPERIMENTAL
Intervention: Medication management
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Family psychosocial interventions
Number of subjects: 61